Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees
Michael D. Chuong(Baptist Hospital of Miami), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Joe Y. Chang(The University of Texas MD Anderson Cancer Center), Smith Apisarnthanarax(University of Washington), Jason K. Molitoris(University of Maryland, Baltimore), Artūrs Meijers(Paul Scherrer Institute), Christopher L. Hallemeier(Mayo Clinic in Arizona), E. Tryggestad(Mayo Clinic), Minglei Kang(University of Wisconsin–Madison), Antje Knopf(Paul Scherrer Institute), Ming Yang(Mayo Clinic in Florida), Charles B. Simone(New York Proton Center), Bradford S. Hoppe(Jacksonville College), Heng Li(The University of Texas MD Anderson Cancer Center), Xiaodong Zhang(The University of Texas MD Anderson Cancer Center), Wei Liu(WinnMed), Jen Yu(University of Maryland, Baltimore), J. Isabelle Choi(Memorial Sloan Kettering Cancer Center), Huan Giap(University of Miami), Xiaorong Zhu(The University of Texas MD Anderson Cancer Center), Percy Lee(University of California, Los Angeles)
Cited by 11
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
|Journal of the National Comprehensive Cancer Network|2021|1k
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2019|1k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746